Reports Outline Hereditary Angioedemas Study Findings from Creighton University (Addressing the Individualized Needs In Hereditary Angioedema: Managed Care Strategies To Optimize Access To Care): Genetic Diseases and Conditions – Hereditary Angioedemas

2022 JUN 21 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Current study results on Genetic Diseases and Conditions - Hereditary Angioedemas have been published. According to news originating from Omaha, Nebraska, by NewsRx editors, the research stated, “Hereditary angioedema (HAE) is a serious, potentially fatal disease of recurrent swelling of various subcutaneous and submucosal tissues throughout the body. Swelling is mediated by uncontrolled regulation of bradykinin, making it pathologically distinct from other forms of angioedema.”

Financial support for this research came from BioCryst.

Our news journalists obtained a quote from the research from Creighton University, “Diagnosis can be challenging, but distinctions in clinical presentation and laboratory studies can confirm clinical suspicion. Though the disease is rare, the socioeconomic burden of living with and treating HAE is significant for patients and healthcare systems. As a result, there has been a dramatic expansion of treatment options specifically designed for HAE in recent years. Novel treatments are effective in treating swelling attacks, preventing recurrence, and improving patient quality of life.”

According to the news editors, the research concluded: “However, significant differences in the risks, benefits, and cost of treatments must be weighed in the determination of clinical protocols to determine optimal utilization of healthcare resources.”

This research has been peer-reviewed.

For more information on this research see: Addressing the Individualized Needs In Hereditary Angioedema: Managed Care Strategies To Optimize Access To Care. The American Journal of Managed Care, 2022;28. The American Journal of Managed Care can be contacted at: Managed Care & Healthcare Communications Llc, 666 Plainsboro Rd, Ste 300, Plainsboro, NJ 08536, USA.

The news correspondents report that additional information may be obtained from Mark Malesker, Creighton University, Pharm Practice & Med, Omaha, NE 68178, United States.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.37765/ajmc.2022.88822. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)